Cholinergic Agents
Showing 1 - 25 of 5,512
Deprescriptions, Antidepressive Agents, Antipsychotic Agents Trial in Bielefeld, Munich, Witten (PARTNER intervention, Control
Recruiting
- Deprescriptions
- +5 more
- PARTNER intervention
- Control intervention
-
Bielefeld, Germany
- +2 more
Apr 24, 2023
Hyperhidrosis, Oxybutynin, Sweat Gland Diseases Trial in São Paulo (Topical oxybutynin spray, Topical spray, Oral oxybutynin)
Not yet recruiting
- Hyperhidrosis
- +6 more
- Topical oxybutynin spray
- +2 more
-
São Paulo, SP, BrazilIrmandade da Santa Casa de Misericórdia de São Paulo
Oct 27, 2021
Cholinergic Integrity in Down Syndrome in Association With
Recruiting
- Down Syndrome
- +2 more
- [18F]-FEOBV Radiotracer
-
Nashville, TennesseeVanderbilt University Medical Center Clinical Research Center
Jan 31, 2023
Postmenopausal Symptoms, Aging, Alzheimer Trial in Nashville, Burlington (Cholinergic antagonist)
Recruiting
- Postmenopausal Symptoms
- +2 more
- Cholinergic antagonist
-
Nashville, Tennessee
- +1 more
Mar 23, 2022
Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease
Completed
- Pulmonary Disease, Chronic Obstructive
- Tiotropium+Olodaterol
- +3 more
-
Taiwan, ChinaHealth Data Research Center, National Taiwan University
Jan 3, 2023
Cardiac Arrhythmia, Supraventricular Arrhythmia Trial in Lodz (Comparison of atropine and isoprenaline)
Not yet recruiting
- Cardiac Arrhythmia
- Supraventricular Arrhythmia
- Comparison of atropine and isoprenaline
-
Lodz, PolandDepartment of Electrocardiology Medical University of Lodz
Oct 9, 2023
COPD Exacerbation Trial in Copenhagen (Long acting muscarinic antagonists (LAMAs) at bedtime)
Recruiting
- COPD Exacerbation
- Long acting muscarinic antagonists (LAMAs) at bedtime
-
Copenhagen, DenmarkHerlev-Gentofte Hospital
Jan 30, 2023
Autism Spectrum Disorder, Aggression, Irritability Trial in New Haven (Transdermal nicotine, Transdermal )
Completed
- Autism Spectrum Disorder
- +2 more
- Transdermal nicotine
- Transdermal placebo
-
New Haven, ConnecticutYale University
May 4, 2022
Hallucinations, Auditory, Psychosis Trial in New Haven (Rivastigmine Transdermal Product, Scopolamine, Placebo)
Recruiting
- Hallucinations, Auditory
- Psychosis
- Rivastigmine Transdermal Product
- +2 more
-
New Haven, ConnecticutConnecticut Mental Health Center
Mar 2, 2022
During Hyperventilation in Normal Individuals and in Mild and
Recruiting
- Hyperventilation
- +2 more
- Acute Hyperventilation
- +2 more
-
Clayton, Victoria, AustraliaMonash Medical Centre
Oct 3, 2022
Prokinetic Use After Emergency Intestinal Anastomosis Trial in Sohag (Prokinetic Motility Agents as primpiram and gastreg)
Active, not recruiting
- Prokinetic Use After Emergency Intestinal Anastomosis
- Prokinetic Motility Agents as primpiram and gastreg
-
Sohag, EgyptOf medicine, Sohag university hospital
Apr 30, 2022
Mood Disorders, Healthy, Unipolar Depression Trial run by the NIMH (Scopolamine Nasal Spray)
Terminated
- Mood Disorders
- +3 more
- Scopolamine Nasal Spray
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 17, 2021
COPD Exacerbation, Magnesium Sulfate Trial in Lahore (Nebulized Magnesium Sulphate)
Completed
- Chronic Obstructive Pulmonary Disease Exacerbation
- Magnesium Sulfate
- Nebulized Magnesium Sulphate
-
Lahore, Punjab, PakistanFawad Ahmad Randhawa
Jan 22, 2023
Cold Urticaria, Cold Contact Urticaria, Symptomatic Dermographism Trial in Berlin (CDX-0159)
Active, not recruiting
- Cold Urticaria
- +4 more
-
Berlin, GermanyCharite University
Dec 20, 2022
Visualising Cerebral and Peripheral Cholinergic Nerves in
Recruiting
- Dementia With Lewy Bodies
- +3 more
- PET-CT using FEOBV
- +3 more
-
Aarhus N, DenmarkDepartment of Nuclear medicine and PET, Aarhus University Hospit
May 19, 2022
Alzheimer Trial in Mineola (Donepezil Hydrochloride, Placebo)
Completed
- Alzheimer Disease
- Donepezil Hydrochloride
- Placebo
-
Mineola, New YorkWinthrop-University Hospital
Jan 13, 2021
Cholinergic Urticaria Trial in Germany (LEO 152020, LEO 152020 )
Completed
- Cholinergic Urticaria
- LEO 152020
- LEO 152020 placebo
-
Aachen, Germany
- +5 more
Sep 1, 2022
Delirium on Emergence Trial in Zagazig (ketofol, dexmedetomidine, normal saline)
Completed
- Delirium on Emergence
- ketofol
- +2 more
-
Zagazig, Alsharqia, EgyptFaculty of medicine, zagazig university
Jul 15, 2022
Rheumatoid Arthritis Trial in United States (SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway
Active, not recruiting
- Rheumatoid Arthritis
- SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway System
-
Aventura, Florida
- +3 more
Apr 22, 2021
Inflammation Trial in Las Cruces (Occipito-Atlantal Decompression (OA DC), Sham Occipito-Atlantal Decompression (Sham OA DC),
Recruiting
- Inflammation
- Occipito-Atlantal Decompression (OA DC)
- +5 more
-
Las Cruces, New MexicoBurrell College of Osteopathic Medicine
Jan 28, 2022
Subjective Cognitive Decline Trial in Nashville (Mecamylamine Challenge, Placebo Comparator Challenge)
Recruiting
- Subjective Cognitive Decline
- Mecamylamine Challenge
- Placebo Comparator Challenge
-
Nashville, TennesseeVanderbilt University Medical Center
Dec 19, 2022
Cocaine Dependence Trial in São Paulo (Biperiden, Placebo)
Completed
- Cocaine Dependence
- Biperiden
- Placebo
-
São Paulo, BrazilUDED - Drug Dependence Unit
Sep 18, 2020
Patients Suffered Substance Abuse Related Voiding Dysfunction
Recruiting
- Voiding Dysfunction
- Substance Abuse
- First line treatment: oral NSAID and anticholinergic agents
- +3 more
-
Shatin, Hong KongPrince of Wales Hospital
Mar 9, 2022
Schizophrenia, Schizoaffective Disorder, Healthy Trial in New Haven (11C-EMO - A Novel PET Radiotracer for Muscarinic M1
Recruiting
- Schizophrenia
- +2 more
- 11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor
-
New Haven, ConnecticutConnecticut Mental Health Center
Sep 16, 2022